State of Alaska Department of Revenue Acquires 5,223 Shares of Privia Health Group, Inc. $PRVA

State of Alaska Department of Revenue boosted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 9.1% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 62,406 shares of the company’s stock after buying an additional 5,223 shares during the period. State of Alaska Department of Revenue owned approximately 0.05% of Privia Health Group worth $1,435,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. US Bancorp DE increased its position in shares of Privia Health Group by 2.4% during the first quarter. US Bancorp DE now owns 18,487 shares of the company’s stock worth $415,000 after acquiring an additional 429 shares in the last quarter. Park Avenue Securities LLC boosted its stake in Privia Health Group by 3.6% in the 1st quarter. Park Avenue Securities LLC now owns 15,229 shares of the company’s stock worth $342,000 after purchasing an additional 532 shares during the period. CWM LLC increased its holdings in Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after purchasing an additional 604 shares in the last quarter. GAMMA Investing LLC increased its holdings in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after purchasing an additional 1,521 shares in the last quarter. Finally, Smartleaf Asset Management LLC raised its stake in shares of Privia Health Group by 24.5% in the 1st quarter. Smartleaf Asset Management LLC now owns 9,060 shares of the company’s stock valued at $205,000 after purchasing an additional 1,785 shares during the period. Institutional investors own 94.48% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on PRVA. Zacks Research raised Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 19th. Evercore ISI cut their target price on Privia Health Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 9th. Citigroup reaffirmed an “outperform” rating on shares of Privia Health Group in a research report on Friday, August 29th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Privia Health Group in a research note on Saturday, September 27th. Finally, Piper Sandler cut their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research report on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $28.58.

Privia Health Group Price Performance

Privia Health Group stock opened at $24.09 on Friday. The firm has a market cap of $2.96 billion, a PE ratio of 219.02, a price-to-earnings-growth ratio of 3.29 and a beta of 0.83. The stock’s fifty day moving average price is $21.99 and its two-hundred day moving average price is $22.42. Privia Health Group, Inc. has a one year low of $16.47 and a one year high of $26.09.

Privia Health Group (NASDAQ:PRVA) last released its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). The company had revenue of $521.15 million for the quarter, compared to the consensus estimate of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business’s revenue was up 23.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.19 earnings per share. Privia Health Group has set its FY 2025 guidance at EPS. Sell-side analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.